Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on May 11, 2005
J Am Soc Nephrol 16: 2111-2118, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2005010039

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005010039v1
16/7/2111    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wynne, K.
Right arrow Articles by Choi, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wynne, K.
Right arrow Articles by Choi, P.

Clinical Nephrology

Subcutaneous Ghrelin Enhances Acute Food Intake in Malnourished Patients Who Receive Maintenance Peritoneal Dialysis: A Randomized, Placebo-Controlled Trial

Katie Wynne*, Kalli Giannitsopoulou*, Caroline J. Small*, Michael Patterson*, Gary Frost*, Mohammad A. Ghatei*, Edwina A. Brown{dagger}, Stephen R. Bloom* and Peter Choi{dagger}

* Department of Metabolic Medicine, Faculty of Medicine, Imperial College London, Hammersmith Hospital; and {dagger} Directorate of Renal and Transplant Medicine, Hammersmith Hospitals NHS Trust, Charing Cross Hospital, London, United Kingdom

Address correspondence to: Dr. Peter Choi, Renal Services, Ground Floor Pilot Wing, Charing Cross Hospital, Fulham Palace Road, London W6 8RF, UK. Phone: +44-208-846-1754; Fax: +44-208-846-7589; E-mail: p.choi{at}imperial.ac.uk

Received for publication January 11, 2005. Accepted for publication March 29, 2005.

Anorexia and malnutrition confer significant morbidity and mortality to patients with end-stage kidney disease but are resistant to therapy. The aim of this study was to determine whether subcutaneous administration of ghrelin, an appetite-stimulating gut hormone, could enhance food intake in patients who are receiving maintenance peritoneal dialysis and have evidence of malnutrition. The principal outcome measure was energy intake during a measured study meal. Secondary outcome measures were BP and heart rate and 3-d food intake after intervention. Nine peritoneal dialysis patients with mild to moderate malnutrition (mean serum albumin 28.6 ± 5.0 g/L, total cholesterol 4.4 ± 0.6 mmol/L, subjective global assessment score of 5.7 ± 1.7) were given subcutaneous ghrelin (3.6 nmol/kg) and saline placebo in a randomized, double-blind, crossover protocol. Administration of subcutaneous ghrelin significantly increased the group mean absolute energy intake, compared with placebo, during the study meal (690 ± 190 versus 440 ± 250 kcal; P = 0.0062). When expressed as proportional energy increase for each individual, ghrelin administration resulted in immediate doubling of energy intake (204 ± 120 versus 100%; P = 0.0319). Administration of ghrelin maintained a nonsignificant increase in energy intake over 24 h after intervention (2009 ± 669 versus 1579 ± 330 kcal) and was not followed by subsequent underswing (1790 ± 370 versus 1670 ± 530 and 1880 ± 390 versus 1830 ± 530 kcal on days 2 and 3, respectively). Ghrelin administration resulted in a significant fall in mean arterial BP (P = 0.0030 by ANOVA). There were no significant adverse events during the study. Subcutaneous ghrelin administration enhances short-term food intake in dialysis patients with mild to moderate malnutrition.




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Yukawa, D. S. Weigle, C. D. Davis, B. T. Marck, and T. Wolden-Hanson
Peripheral ghrelin treatment stabilizes body weights of senescent male Brown Norway rats at baseline and after surgery
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1453 - R1460.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
O. B. Chaudhri, K. Wynne, and S. R. Bloom
Can Gut Hormones Control Appetite and Prevent Obesity?
Diabetes Care, February 1, 2008; 31(Supplement_2): S284 - S289.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
O. Alvarez-Garcia, E. Garcia-Lopez, J. Rodriguez, H. Gil-Pena, I. Molinos, E. Carbajo-Perez, and F. Santos
Administration of ghrelin to young uraemic rats increases food intake transiently, stimulates growth hormone secretion and does not improve longitudinal growth
Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1309 - 1313.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C.-C. Chang, C.-H. Hung, H.-L. Chen, K.-L. Hwang, and C.-Y. Lin
Peritoneal transport characteristics and dwelling time significantly impact ghrelin clearance in peritoneal dialysis patients
Nephrol. Dial. Transplant., January 1, 2007; 22(1): 224 - 228.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
K. G. Murphy, W. S. Dhillo, and S. R. Bloom
Gut Peptides in the Regulation of Food Intake and Energy Homeostasis
Endocr. Rev., December 1, 2006; 27(7): 719 - 727.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
W. S Dhillo, K. G Murphy, and S. Bloom
Endocrinology: the next 60 years.
J. Endocrinol., July 1, 2006; 190(1): 7 - 10.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. Kleinz, J. J. Maguire, J. N. Skepper, and A. P. Davenport
Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man
Cardiovasc Res, January 1, 2006; 69(1): 227 - 235.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. W, Y. PX, L. BM, C. RD, M. DL, M. RH, I. H, O. MH, W. K, B.-J. K, et al.
Anorexia and Cachexia in Renal Failure--Is Leptin the Culprit?: Role of Leptin and Melanocortin Signaling in Uremia-Associated Cachexia. J Clin Invest 115: 1659-1665, 2005
J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2245 - 2250.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP